ArticleLeukemia2021
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.
Abstract read
In one paragraph
Article in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis.Hematological oncology · 2023Pooled it
- Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.British journal of haematology · 2021Trial
- Article
- COVID-19 outcomes in patients with cancer: Findings from the University of California health system database.Cancer medicine · 2022Article
- The immune landscape in BCR-ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy.British journal of haematology · 2022Review
- Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios.Cancers · 2021Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
37 authors.
Richard A SalisburyNIHR Biomedical Research Centre and MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-3500-3215
Natalia Curto-GarciaDepartment of Haematology, Guys and St Thomas' NHS Foundation Trust, London, UK.
Jennifer O'SullivanNIHR Biomedical Research Centre and MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Frederick ChenDepartment of Haematology, Barts Health NHS Trust, London, UK.
Paolo PolzellaDepartment of Haematology, Buckinghamshire Healthcare NHS Trust, Aylesbury, UK.
Anna L GodfreyDepartment of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
James RussellDepartment of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Steven KnapperDivision of Cancer and Genetics, Cardiff University, Cardiff, UK.
John WillanDepartment of Haematology, Frimley Health NHS Foundation Trust, Slough, UK.ORCID http://orcid.org/0000-0001-8700-2073
Rebecca FrewinDepartment of Haematology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK.
Shivani JoshiDepartment of Haematology, Guys and St Thomas' NHS Foundation Trust, London, UK.
Siamak AramiDepartment of Haematology, London Northwest Healthcare University NHS Trust, Harrow, UK.
Sarah BurnsDepartment of Haematology, Manchester University NHS Foundation Trust, Manchester, UK.
Chun Huat TehDepartment of Haematology, Western General Hospital, Edinburgh, UK.
Frances WadelinDepartment of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Jaymathi DhanapalDepartment of Haematology, Royal Berkshire NHS Foundation Trust, Reading, UK.
Pratap NeelakantanDepartment of Haematology, Royal Berkshire NHS Foundation Trust, Reading, UK.
Dragana MilojkovicCentre for Haematology, Imperial College London, London, UK.
Beth PsailaNIHR Biomedical Research Centre and MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Richard SzydloCentre for Haematology, Imperial College London, London, UK.
Sebastian FrancisDepartment of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Catherine CargoDepartment of Haematology, The Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Manish JainDepartment of Haematology, The Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Andrew McGregorDepartment of Haematology, The Newcastle upon Tyne Teaching Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle, UK.
Louise WallisDepartment of Haematology, The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, UK.
Andrew DuncombeDepartment of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Hayder HusseinDepartment of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Peter DyerDepartment of Haematology, University Hospitals of North Midlands NHS Trust, Stoke, UK.
Laura MunroDepartment of Haematology, York Teaching Hospital NHS Foundation Trust, York, UK.
Lee BondDepartment of Haematology, York Teaching Hospital NHS Foundation Trust, York, UK.
Mary Frances McMullinCentre for Medical Education, Queen's University, Belfast, UK.ORCID http://orcid.org/0000-0002-0773-0204
Tim C P SomervailleLeukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.
Mamta GargDepartment of Haematology, University Hospitals of Leicester NHS Foundation Trust, Leicester, UK.
Mallika SekharDepartment of Haematology, Royal Free London NHS Foundation Trust, London, UK.
Claire HarrisonDepartment of Haematology, Guys and St Thomas' NHS Foundation Trust, London, UK.
Adam J Mead *NIHR Biomedical Research Centre and MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. Adam.mead@imm.ox.ac.uk.ORCID http://orcid.org/0000-0001-8522-1002
Andrew J Innes *Centre for Haematology, Imperial College London, London, UK. a.innes@imperial.ac.uk.ORCID http://orcid.org/0000-0003-0918-8882
Funding
Cancer Research UK 26988Cancer Research UK 27125Cancer Research UK 27723Cancer Research UK 28051Cancer Research UK 29034Cancer Research UK 29389Medical Research Council G84/6443Medical Research Council MR/L006340/1Medical Research Council MR/S001190/1
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultAgedAged, 80 and overCOVID-19Disease ManagementFemaleHumansMaleMiddle AgedMyeloproliferative DisordersSARS-CoV-2Survival AnalysisUnited Kingdom
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.